0001127602-21-029702.txt : 20211119
0001127602-21-029702.hdr.sgml : 20211119
20211119162804
ACCESSION NUMBER: 0001127602-21-029702
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211117
FILED AS OF DATE: 20211119
DATE AS OF CHANGE: 20211119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Petersohn Walter
CENTRAL INDEX KEY: 0001501954
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-16211
FILM NUMBER: 211428694
MAIL ADDRESS:
STREET 1: C/O DENTSPLY SIRONA INC
STREET 2: 13320 BALLANTYNE CORPORATE PLACE
CITY: CHARLOTTE
STATE: NC
ZIP: 28277
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DENTSPLY SIRONA Inc.
CENTRAL INDEX KEY: 0000818479
STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843]
IRS NUMBER: 391434669
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13320 BALLANTYNE CORPORATE PLACE
CITY: CHARLOTTE
STATE: NC
ZIP: 28277-3607
BUSINESS PHONE: 844-546-3722
MAIL ADDRESS:
STREET 1: 13320 BALLANTYNE CORPORATE PLACE
CITY: CHARLOTTE
STATE: NC
ZIP: 28277-3607
FORMER COMPANY:
FORMER CONFORMED NAME: DENTSPLY INTERNATIONAL INC /DE/
DATE OF NAME CHANGE: 19930630
FORMER COMPANY:
FORMER CONFORMED NAME: GENDEX CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-11-17
0000818479
DENTSPLY SIRONA Inc.
XRAY
0001501954
Petersohn Walter
13320 BALLANTYNE CORPORATE PLACE
CHARLOTTE
NC
28277
1
Chief Commercial Officer
Common Stock
2021-11-17
4
S
0
34068
54.297
D
36487.1034
D
Common Stock
2021-11-17
4
S
0
10747
54.0832
D
25740.1034
D
Common Stock
2021-11-17
4
M
0
17748
47.41
A
43488.1034
D
Common Stock
2021-11-17
4
S
0
17748
54.107
D
25740.1034
D
Common Stock
2021-11-17
4
M
0
9300
40.12
A
35040.1034
D
Common Stock
2021-11-17
4
S
0
9300
54.085
D
25740.1034
D
Common Stock
2021-11-17
4
M
0
9134
49.29
A
34874.1034
D
Common Stock
2021-11-17
4
S
0
9134
54.123
D
25740.1034
D
Common Stock
2021-11-17
4
M
0
5434
47.84
A
31174.1034
D
Common Stock
2021-11-17
4
S
0
5434
54.094
D
25740.1034
D
Stock Option (Right to Buy)
47.41
2021-11-17
4
M
0
17748
0
D
2024-11-25
Common Stock
17748
0
D
Stock Option (Right to Buy)
40.12
2021-11-17
4
M
0
9300
0
D
2028-08-09
Common Stock
9300
0
D
Stock Option (Right to Buy)
49.29
2021-11-17
4
M
0
9134
0
D
2029-03-12
Common Stock
9134
4566
D
Stock Option (Right to Buy)
47.84
2021-11-17
4
M
0
5434
0
D
2030-03-04
Common Stock
5434
10866
D
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.19 to $54.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.05 to $54.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.06 to $54.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.03 to $54.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.00 to $54.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.03 to $54.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
This option is fully vested and exercisable.
This option is fully vested and exercisable.
Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 12, 2022.
Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 4, 2023.
/s/ Dane Baumgardner, Attorney-In-Fact for Walter Petersohn
2021-11-19